Please login to the form below
Cornerstone Therapeutics
This page shows the latest Cornerstone Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Chiesi hits the acquisition trail again
company Cornerstone Therapeutics. ... The value of the deal is around $107m and all in all values Cornerstone at some $255m.
Latest news
-
Biologics buoyant
Three of the deals, with Amplimmune, FivePrime Therapeutics and Genmab, focus on biologics. ... 84+. Cornerstone Therapeutics/Targacept . Alpha-7 and other nicotinic receptor targeting compounds. Preclinical .
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Deal Watch table for September 2013
Cornerstone Therapeutics/ Chiesi Farmaceutici. Acquisition (42 per cent). US speciality pharmaceutical company focused hospital and niche respiratory products. ... Cornerstone Therapeutics, respectively.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Senior Copywriter
-
Salary TBC
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer opens AI-enabled drug discovery center in UK
- Roche reports continued growth in Q3, despite biosimilar competition
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- The best in the UK healthcare system celebrated at QiC Diabetes awards 2019
- Merck wins CHMP recommendation for Ebola vaccine
- Roche scores another FDA approval for Xofluza
- CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal
- AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs
- A snapshot of Crescendo Biologics
PMHub
OUTiCO
Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...
Latest intelligence
- A snapshot of Crescendo Biologics
- PME talks to CEO Theodora Harold...
- eyeforpharma Marketing and Customer Innovation Europe
- By Richard Springham...
- The Golden Goose
- Why it’s so hard for the US to curb runaway drug prices...
Quick links
Infographics
